Aspen Aerogels reported a strong first quarter of 2024, with a 37% increase in revenue to $94.5 million compared to $45.6 million in Q1 2023. The company's Adjusted EBITDA was $12.9 million, a significant improvement from $(13.9) million in the same period last year. They are raising 2024 baseline Adjusted EBITDA outlook by 83% and expecting positive net income for 2024.
Q1 2024 revenue reached $94.5 million, compared to $45.6 million in Q1 2023.
Net loss improved to $1.8 million, compared to a net loss of $16.8 million in Q1 2023.
Adjusted EBITDA was $12.9 million, a significant increase from $(13.9) million in Q1 2023.
The company is raising its 2024 baseline Adjusted EBITDA outlook by 83% and expects positive net income for the year.
Aspen updated its 2024 full year outlook, expecting revenue growth greater than 47% to over $380 million and raised its 2024 baseline Adjusted EBITDA outlook by 83%, to $55 million. They anticipate positive net income for the year.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance